Biotech Innovations
Xene Biolabs delivers premium research peptides and longevity compounds engineered for scientific precision, advanced biotechnology innovation
Biotech Innovations
Xene Biolabs delivers premium research peptides and longevity compounds engineered for scientific precision, advanced biotechnology innovation
5AMINO-10X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
NNMT (Nicotinamide N-Methyltransferase) inhibitor. By inhibiting NNMT in adipose tissue, 5-Amino-1MQ increases intracellular NAD+ levels, activates SIRT1 and AMPK pathways, enhances energy expenditure, promotes fat cell shrinkage, and supports metabolic rate upregulation. No direct GH or IGF-1 effects.
Dosing Protocol
50–100 mg/day oral.
50 mg capsules:
- 50 mg/day = 1 capsule
- 100 mg/day = 2 capsules
Timing: Morning, with or without food.
Cycle Length: 8–12 weeks.
Critical: Daily consistency is important for optimal results. Fasting is not required. Best used alongside a calorie-controlled diet and regular exercise program to maximize metabolic and body-composition benefits.
AOD-9604 | AOD-X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.
BPC+TB-10X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Healing Peptides | Half-life: BPC ~4h, TB-500 7-14 days
Mechanism
BPC-157 = gastric peptide, upregulates growth factors, angiogenesis, gut healing. TB-500 = Thymosin Beta-4 fragment, actin regulation, cell migration.
Dosing Protocol
Reconstitution: 5 mg each + 2.5 mL BAC = 2 mg/mL. 250 mcg = 0.125 mL = 12.5 units.
Critical: BPC site injection for local effect. TB-500 systemic. Can mix in same syringe.
CJC + IPA + Sermorelin
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category:Dual GHRH Analogues + GHRP | Half-life: CJC-1295 (No DAC) ~30 min, Ipamorelin ~2 h, Sermorelin ~10–20 min
Mechanism
Dual GHRH analogues with a selective GHRP enhance GH pulsatility, supporting recovery, muscle repair, and lean mass.
Dosing Protocol
500 mcg–1 mg SubQ, administered 1–2 times daily; pre-sleep preferred, with post-workout dosing as a secondary option.
Critical: Sermorelin has an extensive safety record among GHRH analogues, making this blend suitable for recovery-focused protocols and individuals new to GH secretagogues.
CJC + IPA + Tesamorelin
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category:Dual GHRH Analogues + GHRP | Half-life: CJC-1295 (No DAC) ~30 min, Ipamorelin ~2 h, Sermorelin ~10–20 min
Mechanism
Dual GHRH analogues with a selective GHRP enhance GH pulsatility, supporting recovery, muscle repair, and lean mass.
Dosing Protocol
500 mcg–1 mg SubQ, administered 1–2 times daily; pre-sleep preferred, with post-workout dosing as a secondary option.
Critical:
Sermorelin has an extensive safety record among GHRH analogues, making this blend suitable for recovery-focused protocols and individuals new to GH secretagogues.
CJC NO DAC
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: GHRH + GHRP | Half-life: CJC w/ DAC 6-8 days, Ipamorelin 2h
Mechanism
CJC-1295 = GHRH analog with DAC for extended half-life. Ipamorelin = selective ghrelin agonist. Combo gives sustained GH release with minimal prolactin/cortisol.
Dosing Protocol
Reconstitution: 5 mg each + 2.5 mL BAC = 2 mg/mL each. 100 mcg = 0.05 mL = 5 units of each.
Critical: Take fasted. CJC w/ DAC causes GH bleed, no DAC requires multi-daily dosing.
EPITHALON-10X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Telomerase Modulator / Longevity Peptide
Mechanism
Epithalon modulates telomerase activity, supports telomere maintenance, influences melatonin secretion, and regulates circadian rhythm in cellular aging research models.
Dosing Protocol
5–10 mg daily SubQ or IM for 10–20 days; alternative 5 mg every other day for 4–6 weeks, evening dosing preferred.
Critical:
Critical: Best studied in short cycles (10–20 days); evening administration preferred due to circadian (melatonin-linked) activity. Effects vary significantly by individual biology and research conditions.
GHKCU-50X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.
Gonadorelin | GONA-X (2 mg)
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: GnRH Agonist | Half-life: 2-4 min IV, 20-40 min SubQ
Mechanism
Synthetic GnRH. Pulsatile use stimulates LH/FSH → testosterone. Continuous use desensitizes pituitary and shuts down HPTA.
Dosing Protocol
Reconstitution: 2 mg + 2 mL BAC = 1 mg/mL. 100 mcg = 0.1 mL = 10 units.
Critical: Pulsatile dosing only. Continuous daily use will shut you down like Lupron.
hGH 191AA | HGH191-X (10 IU)
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Growth Hormone | Half-life: 20-30 min SubQ, 3.5h IV
Mechanism
Identical to endogenous GH. Binds GH receptor → IGF-1 release, lipolysis, anabolism, glucose regulation.
Dosing Protocol
Reconstitution: 10 IU + 1 mL BAC = 10 IU/mL. 2 IU = 0.2 mL = 20 units.
Critical: Monitor glucose, IGF-1, TSH. Can cause insulin resistance, carpal tunnel, edema at high doses.
HGH FRAG- 5X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.
IGF-1LR3
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.
IGF-DES-2X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Growth Factor | Half-life: 20-30 min
Mechanism
Mechanism
DES variant of IGF-1 with N-terminal truncation. 10x more potent than IGF-1 LR3 for acute muscle hyperplasia. Binds muscle cells directly, bypasses IGFBP.
Dosing Protocol
Reconstitution: 1 mg + 1 mL BAC = 1000 mcg/mL. 20 mcg = 0.02 mL = 2 units.
Critical: Take immediately post-training into muscles worked. Must have carbs intra/post.
IPAMORELIN
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: GHRH + GHRP
Mechanism
GHRH analog with DAC for extended half-life. Ipamorelin = selective ghrelin agonist. Combo gives sustained GH release with minimal prolactin/cortisol.
Dosing Protocol
Reconstitution: 5 mg each + 2.5 mL BAC = 2 mg/mL each. 100 mcg = 0.05 mL = 5 units of each.
Critical: Take fasted. CJC w/ DAC causes GH bleed, no DAC requires multi-daily dosing.
Kisspeptin | KISS-X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: GnRH Secretagogue | Half-life: KP10 4 min, KP54 28 min
Mechanism
Master upstream activator of GnRH neurons. Stimulates LH/FSH via hypothalamus. No feedback bypass like hCG.
Dosing Protocol
Critical: Pulsatile dosing. Daily use causes desensitization. Men respond to KP10, women need KP54 or preovulatory timing
MOTS C-10X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Mitochondrial Peptide | Half-life: 2-4h
Mechanism
Mitochondrial-derived peptide. AMPK activation, glucose uptake, mitochondrial biogenesis. Exercise mimetic. Improves insulin sensitivity.
Dosing Protocol
Reconstitution: 10 mg + 2 mL BAC = 5 mg/mL. 5 mg = 1.0 mL = 100 units.
Critical: Take fasted. Best before exercise. Improves with training stimulus.
NAD+ 100 | NAD100-X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Coenzyme | Half-life: IV hours, SubQ 1-2 days
Mechanism
Essential coenzyme for ATP, DNA repair, sirtuins. Declines 50% by age 50. Direct NAD+ vs precursors NMN/NR.
Dosing Protocol
Reconstitution: 100 mg/mL. 50 mg = 0.5 mL = 50 units.
Critical: More isn’t better. 50 mg EOD beats 100 mg daily. Cycle 30 days on/off.
PEG MGF-2X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Muscle Growth Factor | Half-life: 48-72h due to PEGylation
Mechanism
Splice variant of IGF-1 expressed after mechanical stress. Activates satellite cells for muscle repair and growth. PEGylation extends half-life vs MGF.
Dosing Protocol
Reconstitution: 2 mg + 2 mL BAC = 1 mg/mL. 200 mcg = 0.2 mL = 20 units.
Critical: Never use on training days. IGF-1 competes with MGF. Use on rest days only.
Retatrutide | RETA-X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: GLP-1/GIP/Glucagon Tri-Agonist | Half-life: 6 days
Mechanism
Triple incretin agonist. GLP-1 + GIP + glucagon receptor activation. Superior weight loss to Semaglutide/Tirzepatide. Phase 3 trials.
Dosing Protocol
Critical: Slow titration mandatory. Severe nausea/vomiting if escalated too fast. Not FDA-approved yet. Research only.
SELANK
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Anxiolytic Nootropic Peptide
Mechanism
Selank is a nootropic peptide that reduces anxiety, modulates GABA, serotonin, dopamine, increases BDNF, improves cognition, focus, and stress resilience.
Dosing Protocol
250–500 mcg intranasal or SubQ, 1–2 times daily, morning or pre-stress events, 2–4 weeks cycle.
Critical: Non-sedating anxiolytic, no dependency, well tolerated, supports cortisol reduction and cognitive performance.
Sermorelin | SERM-X (2 mg)
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: GHRH Analog | Half-life: 10-20 min
Mechanism
GHRH 1-29 analog. Stimulates pituitary GH release. Preserves negative feedback, lower risk of desensitization vs GHRP-2/6.
Dosing Protocol
Reconstitution: 2 mg + 2 mL BAC = 1 mg/mL. 300 mcg = 0.3 mL = 30 units.
Critical: Take on empty stomach. Carbs/insulin blunt GH pulse. Wait 2h after last meal.
SS-31
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Mitochondria-Targeting Peptide
Mechanism
SS-31 targets mitochondria, stabilizes cardiolipin, reduces ROS, improves ATP production, protects heart and muscle energy metabolism, enhances cellular efficiency.
Dosing Protocol
2–4 mg daily SubQ, once daily morning use, 8–12 weeks cycle or long-term research administration.
Critical: Strong mitochondrial protective peptide improving cardiac function, endurance, and oxidative stress resistance in research models.
TB500
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.